111 related articles for article (PubMed ID: 464786)
1. [Mexiletine, a drug with anti-arrhythmic action. Experimental research on the cardiovascular system].
Caputi AP; Rossi F; Lampa E; Imperatore A; Visone C; Marmo E
Arch Sci Med (Torino); 1979; 136(1):1-15. PubMed ID: 464786
[TBL] [Abstract][Full Text] [Related]
2. [The anti-arrhythmic action of mexiletine: experimental study].
Ciraolo O; Quartarone M; Corica F; D'Andrea Petrelli L; Barbera N; Ceruso D
G Clin Med; 1983 Nov; 64(11):483-90. PubMed ID: 6667804
[No Abstract] [Full Text] [Related]
3. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
Carmeliet E
Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
[No Abstract] [Full Text] [Related]
4. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of sympathetic nervous system by mexiletine, an antiarrhythmic agent, and its antagonism against ouabain.
Kitagawa H; Takeda F; Kohei H
Arzneimittelforschung; 1985; 35(1A):356-9. PubMed ID: 4039173
[TBL] [Abstract][Full Text] [Related]
6. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide.
Beltrame J; Aylward PE; McRitchie RJ; Chalmers JP
J Cardiovasc Pharmacol; 1984; 6(3):483-90. PubMed ID: 6202976
[TBL] [Abstract][Full Text] [Related]
7. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
Marmo E; Rossi F; Lampa E; Chieppa S; Apolito A; Del Vecchio F
Arch Sci Med (Torino); 1978; 135(1):57-78. PubMed ID: 25058
[TBL] [Abstract][Full Text] [Related]
8. [Sodium phosphocreatine and the cardiovascular and respiratory systems].
Lampa E; Perna D; Giasi M; Imperatore A; Visone C; Somma A; Ottavo R; Matera G; Ruggiero E; Pierri T; Marmo E
Arch Sci Med (Torino); 1981; 138(3):365-98. PubMed ID: 7032463
[TBL] [Abstract][Full Text] [Related]
9. Possible adverse effects on the cardiovascular system of an antiarrhythmic drug mexiletine.
Rossi F; Ruggiero E; Scafuro MA; Giasi M; Mazzeo V; Bile G; Lamparelli E; Marmo E
Arch Toxicol Suppl; 1984; 7():510-4. PubMed ID: 6596024
[TBL] [Abstract][Full Text] [Related]
10. [Méxiletine. Action on heart rhythm disorders].
Lellouche D; Bougherbal R
Nouv Presse Med; 1975 Feb; 4(5):351-2. PubMed ID: 1093125
[No Abstract] [Full Text] [Related]
11. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
Rolli A; Bonatti V; Finardi A; Favaro L; Botti G
G Ital Cardiol; 1981; 11(4):468-76. PubMed ID: 6169578
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic effects of a new anti-arrhythmic agent, mexiletine (Kö 1173) in ischaemic heart disease.
Saunamäki
Cardiovasc Res; 1975 Nov; 9(6):788-92. PubMed ID: 1203917
[TBL] [Abstract][Full Text] [Related]
13. Mexiletine/quinidine combination therapy: electrophysiologic correlates of anti-arrhythmic efficacy.
Duff HJ; Mitchell LB; Wyse DG; Gillis AM; Sheldon RS
Clin Invest Med; 1991 Oct; 14(5):476-83. PubMed ID: 1660369
[TBL] [Abstract][Full Text] [Related]
14. Mexiletine and tocainide: orally active congeners of lidocaine.
Wulf BG
Clin Pharm; 1983; 2(4):340-6. PubMed ID: 6411416
[No Abstract] [Full Text] [Related]
15. [The effect of the new antiarrhythmic drug mexiletine on sinus node and intracardiac conduction in man (author's transl)].
Seipel L; Breithardt G; Schoerner U
Z Kardiol; 1978 Nov; 67(11):766-70. PubMed ID: 726555
[No Abstract] [Full Text] [Related]
16. [Clinical study of the ventricular anti-arrhythmia effects of oral and injectable mexiletine].
Fauchier JP; Charbonnier B; Latour F; Brochier M; Raynaud R
Ann Cardiol Angeiol (Paris); 1978; 27(2):173-8. PubMed ID: 655605
[No Abstract] [Full Text] [Related]
17. [Carotid sinus baroreceptor reactivity and chemoreceptor reactivity of the carotid body in anesthetized dogs treated with endocarotid administration of beta-adrenolytics].
Ottavo R; Marfella A; Ruta A; Pentimalli D; De Marco G; D'Angelo G; Scognamiglio M; Spadaro R; De Gennaro G
Minerva Anestesiol; 1982 Apr; 48(4):203-8. PubMed ID: 6127654
[No Abstract] [Full Text] [Related]
18. [Experimental studies of the specificity and aspecificity of a beta-adrenolytic agent, bunitrolol (Kö 1366)].
Marmo E; Lampa E; Rossi F; Caputi AP; Chieppa S; Vacca C; Giordano L; Pedone P
Arch Sci Med (Torino); 1978; 135(1):15-56. PubMed ID: 25057
[TBL] [Abstract][Full Text] [Related]
19. [Electrophysiological study of the mexiletine (author's transl)].
Ebagosti A; Lodovici F; Escojido H; Torresani J; Jouve A
Ann Cardiol Angeiol (Paris); 1979; 28(3):181-8. PubMed ID: 507723
[No Abstract] [Full Text] [Related]
20. Cardiovascular effects of 15(S) 15 methyl-PGF2 alpha.
Filippelli W; Filippelli A; Caloprice A; Vacca C; Bile G; Spadaro R; Marmo E
J Med; 1982; 13(5-6):387-98. PubMed ID: 6963330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
